97 Medication use by insurance coverage in the Southern Cone of Latin America 4 questionnaire: 12-Country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95. 26. Subar A, Thompson F, Kipnis V, Midthune D, Hurwitz P, McNutt S, et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: the Eating at America’s Table Study. Am J Epidemiol. 2001;154(12):1089–99 27. Elorriaga N, Irazola VE, Defagó MD, Britz M, Martínez-Oakley SP, Witriw AM, et al. Validation of a self-administered FFQ in adults in Argentina, Chile and Uruguay. Public Health Nutr. 2015 Jan 14;18(1):59–67. 28. Lumley T. Analysis of Complex Survey Samples [Internet]. 2021. Available from: http://r-survey.r-forge.r-project.org/ survey/ 29. RStudio Team. RStudio: Integrated Development Environment for R. Boston, MA: RStudio, Inc.; 2016. 30. Travetto CM , Bacigalup JJ, Martínez JM, De Abreumtsac M, Mariani J, Liprandi AS, Charask A, Gagliardi J, Doval HC, de Cajer C. Estatinas al alta en la coronariopatía aguda en los últimos 10 años. Registro Epi-Cardio. Rev Arg Cardiol. 2016;84:459–67. 31. Rosende A, Caniaggia C, Casucelli J, Miranda M, Comtesse D, Charask A, et al. Approach on the use of statins in a sample of doctors from Argentina. The COFEMA study. Rev Argent Cardiol 2016;84(6) 32. Blais JE, Wei Y, Yap KK, Alwafi H, Ma TT, Brauer R, et al. Trends in lipid-modifying agent use in 83 countries. Atherosclerosis. 2021;328:44–51. 33. Guadamuz JS, Shooshtari A, Qato DM. Global, regional and national trends in statin utilisation in high-income and low/middle-income countries, 2015-2020. BMJ Open. 2022;12(9):1–7. 34. Marzà-Florensa A, Drotos E, Gulayin P, Grobbee DE, Irazola V, Klipstein-Grobusch K, et al. Prevalence of Cardioprotective Medication Use in Coronary Heart Disease Patients in South America: Systematic review and Meta-Analysis. Glob Heart. 2022;17(1):37. 35. Berwanger O, e Mattos LAP, Martin JFV, Lopes RD, Figueiredo EL, Magnoni D, et al. Evidence-based therapy prescription in high-cardiovascular risk patients: The REACT study. Arq Bras Cardiol. 2013;100(3):212–20. 36. Nazzal C, Frenz P, Alonso FT, Lanas F. Effective universal health coverage and improved 1-year survival after acute myocardial infarction: The Chilean experience. Health Policy Plan. 2016;31(6):700–5. 37. Fernández C, Manzur JL, Gollán D, Kreplak N, Monsalvo M. Guía de Medicamentos Esenciales: Formulario Terapéutico en el Primer Nivel de Atención. Minist Salud la Nación. 2010;153. 38. Salud M de. Fondo de Farmacias. 2015 [cited 2022 Jun 7]. Available from: https://www.minsal.cl/fofar/
RkJQdWJsaXNoZXIy MTk4NDMw